is a renowned center of excellence for the study of retinal diseases, established in 1993. Led by Dr. Gregg Kokame and Dr. Sarah Read, both trained at the prestigious Bascom Palmer Eye Institute, HMRI has gained worldwide recognition for its groundbreaking research and participation in over 60 multi-centered clinical trials. Their research has led to FDA approval of revolutionary treatments for retinal diseases, making HMRI the only clinical center in Hawaii to achieve such milestones. With a focus on macular degeneration, diabetic retinopathy, and retinal vein occlusions, HMRI continues to lead the way in developing new treatments and improving patient outcomes. HMRI's research program has not only resulted in FDA-approved treatments but has also contributed to a better understanding of diseases like polypoidal choroidal vasculopathy (PCV). Dr. Kokame's unique clinical trials studying PCV have shed light on its management and characteristics in different ethnicities, leading to presentations at national meetings and recognition in the field. With a commitment to excellence and a dedication to advancing retinal care, HMRI remains at the forefront of retinal research and clinical trials, offering hope and innovative solutions to patients with retinal diseases.Generated from the website
